Abstract

BackgroundThe 20-item BRAF-MDQ was developed in the UK to measure RA fatigue, with a total score and 4 distinct subscales reflecting different fatigue concepts; there are 35 translations. If the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
THU0593 Validity of The Bristol RA Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) and Rheumatoid Arthritis Impact of Disease (RAID) Scale across 6 European Countries
S Hewlett ... G Schett
Annals of the Rheumatic Diseases | VOL. 75
S Hewlett, et. al.S Hewlett ... G Schett
01 Jun 2016
The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries.
Rosemary Greenwood ... Anna Molto
Rheumatology (Oxford, England) | VOL. 57
Rosemary Greenwood, et. al.Rosemary Greenwood ... Anna Molto
26 Oct 2017
Measuring fatigue in rheumatoid arthritis: A cross‐sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi‐Dimensional questionnaire, visual analog scales, and numerical rating scales
Rosemary Greenwood ... John Kirwan
Arthritis Care & Research | VOL. 62
Rosemary Greenwood, et. al.Rosemary Greenwood ... John Kirwan
01 Nov 2010
Development and Validation of the Voice Fatigue Handicap Questionnaire (VFHQ): Clinical, Psychometric, and Psychosocial Facets
Nico Paolo Paolillo ... Giuseppe Pantaleo
Journal of Voice | VOL. 29
Nico Paolo Paolillo, et. al.Nico Paolo Paolillo ... Giuseppe Pantaleo
26 Sep 2014
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers